Quinlan Paul T (CIK 1333277) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Sell ORKA (3,630 shares), Buy ORKA (42,000 shares), Buy ORKA (10,000 shares), Sell ORKA (10,434 shares), Sell ORKA (14,696 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | Sell | 3,630 | $384,963 |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | Buy | 42,000 | $525,000 |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | Buy | 10,000 | $78,000 |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | Sell | 10,434 | $1.1M |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | Sell | 14,696 | $1.6M |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | Sell | 10,200 | $1.1M |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | Sell | 9,193 | $1.0M |
| 2026-08-14 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | Sell | 3,847 | $427,547 |
| 2026-06-15 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | Sell | 733 | $51,083 |
| 2026-03-17 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | Sell | 733 | $30,273 |
| 2026-01-23 | Oruka Therapeutics, Inc. (ORKA) | General Counsel | Buy | 32,500 | $0 |
Source: SEC Form 4 filings · as of 2026-08-14